Asia Regenerative Medicine Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 11

Asia Regenerative Medicine General Information

Description

Developer of stem cell and tissue engineering technologies focused on addressing kidney disease. The company specailises in stem cells, exosomes, dialysis enhancement therapies, implantable bioartificial kidneys and differentiated cell platforms, enabling solutions for chronic kidney disease, end-stage renal failure, and organ transplant shortages.

Contact Information

Website
www.asiaregen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11th Floor, Block A, Phase II, Yinxing Zhijie
  • Yinxing Science and Technology Park, Longhua District
  • Shenzhen, Guangdong 518110
  • China
+86 185
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • 11th Floor, Block A, Phase II, Yinxing Zhijie
  • Yinxing Science and Technology Park, Longhua District
  • Shenzhen, Guangdong 518110
  • China
+86 185

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Asia Regenerative Medicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 29-Oct-2025 Completed Generating Revenue
4. Later Stage VC 20-Nov-2023 Completed Pre-Clinical Trials
3. Early Stage VC 08-Feb-2023 Completed Pre-Clinical Trials
2. Early Stage VC 17-Jun-2021 Completed Pre-Clinical Trials
1. Grant 13-Feb-2020 $100K Completed Product In Beta Test
To view Asia Regenerative Medicine’s complete valuation and funding history, request access »

Asia Regenerative Medicine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Asia Regenerative Medicine Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Guangdong Dongna Private Equity Fund Management Venture Capital Minority
DYEE Capital Asset Manager Minority
Kangyu Capital Growth/Expansion Minority
Kexi Capital Growth/Expansion Minority
Xiamen Hi-Tech Innovation Center Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Asia Regenerative Medicine FAQs

  • When was Asia Regenerative Medicine founded?

    Asia Regenerative Medicine was founded in 2018.

  • Where is Asia Regenerative Medicine headquartered?

    Asia Regenerative Medicine is headquartered in Shenzhen, China.

  • What is the size of Asia Regenerative Medicine?

    Asia Regenerative Medicine has 100 total employees.

  • What industry is Asia Regenerative Medicine in?

    Asia Regenerative Medicine’s primary industry is Biotechnology.

  • Is Asia Regenerative Medicine a private or public company?

    Asia Regenerative Medicine is a Private company.

  • What is Asia Regenerative Medicine’s current revenue?

    The current revenue for Asia Regenerative Medicine is .

  • Who are Asia Regenerative Medicine’s investors?

    Guangdong Dongna Private Equity Fund Management, DYEE Capital, Kangyu Capital, Kexi Capital, and Xiamen Hi-Tech Innovation Center are 5 of 11 investors who have invested in Asia Regenerative Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process